Canada notifies Prescription Drug List (PDL) of Veterinary and Human Antimicrobials

Department of Health notifies Prescription Drug List (PDL) of Veterinary and Human Antimicrobials.

This Notice of Consultation provides an opportunity to comment on the proposal to: i) amend the "Products for Human Use" part of the Prescription Drug List (PDL) in relation to Erythromycin and Lincomycin (see Table 1a and 1b); and ii) add and amend 14 antimicrobial active ingredients or their salts or derivatives to the "Products for Veterinary Use" part of the PDL, including the removal of Tilmicosin's and Tylosin's qualifier (see Table 2a – 2d).

Objective and rationale, including the nature of urgent problems where applicable: Protection of human health or safety

Products covered: Prescription status of medicinal ingredients for human use

Proposed date of adoption: 18 September 2017

Proposed date of entry into force: 18 March 2018

Final date for comments: 18 September 2017

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.